Malaria: On a mission to block transmission

The controlled infection of volunteers with Plasmodium falciparum parasites could provide a platform to evaluate new drugs and vaccines aimed at blocking malaria transmission.
  1. Amanda Ross  Is a corresponding author
  2. Nicolas MB Brancucci
  1. Swiss Tropical and Public Health Institute, Switzerland
  2. University of Basel, Switzerland

Life inside a human host is fraught with danger. Plasmodium falciparum malaria parasites need to be highly adapted to compete for resources and to take their chances with the immune system. The same degree of specialization is needed to survive inside the mosquito, and for the transitions from human to mosquito and vice versa. These seemingly incompatible needs are met by a life cycle that involves morphing into a series of different forms.

Under the microscope, a blood sample may reveal different stages of the parasite: asexual parasites that replicate and prolong the infection, and sexual stages called gametocytes, the form that transmits the infection from human to mosquito. Both male and female gametocytes arise when a small proportion of asexual parasites stop replication and commit to sexual development instead. After maturation they are either taken up by a feeding mosquito or die. Sex and transmission are inextricably linked. Fertilization occurs inside the mosquito gut within an hour of feeding and leads to several developmental phases inside the insect vector, after which parasites are ready to infect a new human host (Sinden, 2017).

Most licensed antimalarial drugs target the asexual forms of the parasite. These stages are the most abundant and cause the symptoms of malaria (Sinden, 2017; Nilsson et al., 2015). As the burden of disease has declined in many regions and the focus is shifting towards malaria elimination, the searchlight beam now falls onto other stages. On paper, gametocytes are a good target to break the circle of transmission: they are the only form capable of infecting mosquitoes and their low number creates a population bottleneck.

However, efforts to introduce new drugs and vaccines that target gametocytes and prevent malaria transmission face an obstacle: there is no method to directly evaluate their success in humans. Clinical studies in malaria patients can demonstrate the effect of drugs on asexual parasites, but often fail to capture the dynamics of gametocytes for simple reasons. Gametocytes generally occur at very low densities and are often missed by standard detection methods. They sequester away from the blood stream for eight to twelve days as they mature, and often are not seen at the time of illness. Consequently, the evaluation of drugs is mostly limited to unnatural conditions, such as measuring gametocyte densities in cell cultures or artificially feeding blood infected with gametocytes to mosquitoes.

Now, in eLife, Robert Sauerwein, Teun Bousema and colleagues – including Isaie Reuling as first author – report a promising method to fill this void (Reuling et al., 2018). The researchers – who are based at the Radboud University Medical Center and other universities and non-profit organizations in the UK, United States, Australia and the Netherlands – drew on recent scientific developments in sensitive molecular diagnostic methods, the stage-specificity of drugs and the resurgence of interest in human challenge studies (Farid et al., 2017; Stanisic et al., 2018; Stone et al., 2017).

Reuling et al. deliberately infected volunteers with P. falciparum using Anopheles mosquitoes. The ensuing asexual parasite densities were controlled and eventually cleared using different drugs while allowing the gametocytes to continue development under safe conditions. All of the volunteers yielded circulating gametocytes.

A crucial question is how well this method of generating gametocytes in humans would work to evaluate a compound that blocks transmission. Effects on gametocyte densities can be shown (Collins et al., 2018). However, such densities are only loosely related to transmission success (Churcher et al., 2013). The most relevant measure would be whether or not feeding mosquitoes become infected. Reuling et al. observed that the low gametocyte numbers in the volunteers only sporadically infected mosquitoes, and are aware that this renders conclusions about transmission-blocking activity impossible.

Changing certain elements of the study setup, for example using different drugs, treatment doses, P. falciparum laboratory strains or mosquito species, may overcome this issue. Another possibility could be to enhance gametocyte production by inducing sexual commitment. However, we are only beginning to understand the triggers for this process (Bechtsi and Waters, 2017). Recently, a human lipid was shown to inhibit sexual commitment (Brancucci et al., 2017). Interfering with the underlying regulatory pathway could be exploited in the future. But regardless of how these problems are tackled, questions of how well the system translates into real life settings would need to be addressed carefully.

A side-effect of piloting the method of controlled human infection is the insight into the secret lives of gametocytes. Previously, the most detailed studies of gametocyte dynamics had been made when deliberate infections were used to treat neurosyphilis patients at a time before antibiotics were available (Snounou and Pérignon, 2013). By using highly sensitive and sex-specific detection methods, Reuling et al. add to the pool of knowledge and provide evidence that mature male and female gametocytes first appear in the blood at different times, and that female gametocytes circulate in the blood for longer. The early appearance of mature gametocytes in the peripheral blood of the volunteers further suggests that a fraction of the first wave of parasites entering the blood stream can already be sexually committed.

A system to evaluate potential transmission-blocking strategies in vivo is hugely appealing. In future, an optimized setup that can achieve a higher proportion of infected mosquitoes may help to discover new ways to prevent malaria transmission. The work of Reuling et al. has opened a door.

Red blood cells infected with Plasmodium falciparum parasites.

Malaria parasites have a complex life cycle and different forms of the parasites can be found in the blood. This scanning electron micrograph shows red blood cells infected with the parasite: an asexual stage on the left and a mature gametocyte on the right. Only the gametocytes can infect mosquitoes.

© Brand, 2018. Image courtesy of Françoise Brand, Swiss Tropical and Public Health Institute and University of Basel. Published under a CC BY 4.0 license.

References

Article and author information

Author details

  1. Amanda Ross

    Amanda Ross is in the Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland and the University of Basel, Basel, Switzerland.

    For correspondence
    amanda.ross@swisstph.ch
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6027-5645
  2. Nicolas MB Brancucci

    Nicolas MB Brancucci is in the Department of Molecular Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland and the University of Basel, Basel, Switzerland.

    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0655-3266

Acknowledgements

The authors thank Eilidh Carrington, Natalie Hofmann, Melissa Penny, Matthias Rottmann, Tom Smith and Till Voss for helpful discussions.

Publication history

  1. Version of Record published: February 27, 2018 (version 1)

Copyright

© 2018, Ross et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,242
    Page views
  • 426
    Downloads
  • 2
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Amanda Ross
  2. Nicolas MB Brancucci
(2018)
Malaria: On a mission to block transmission
eLife 7:e35246.
https://doi.org/10.7554/eLife.35246

Further reading

    1. Immunology and Inflammation
    2. Microbiology and Infectious Disease
    Ceri Alan Fielding et al.
    Research Article Updated

    The outcome of infection is dependent on the ability of viruses to manipulate the infected cell to evade immunity, and the ability of the immune response to overcome this evasion. Understanding this process is key to understanding pathogenesis, genetic risk factors, and both natural and vaccine-induced immunity. SARS-CoV-2 antagonises the innate interferon response, but whether it manipulates innate cellular immunity is unclear. An unbiased proteomic analysis determined how cell surface protein expression is altered on SARS-CoV-2-infected lung epithelial cells, showing downregulation of activating NK ligands B7-H6, MICA, ULBP2, and Nectin1, with minimal effects on MHC-I. This occurred at the level of protein synthesis, could be mediated by Nsp1 and Nsp14, and correlated with a reduction in NK cell activation. This identifies a novel mechanism by which SARS-CoV-2 host-shutoff antagonises innate immunity. Later in the disease process, strong antibody-dependent NK cell activation (ADNKA) developed. These responses were sustained for at least 6 months in most patients, and led to high levels of pro-inflammatory cytokine production. Depletion of spike-specific antibodies confirmed their dominant role in neutralisation, but these antibodies played only a minor role in ADNKA compared to antibodies to other proteins, including ORF3a, Membrane, and Nucleocapsid. In contrast, ADNKA induced following vaccination was focussed solely on spike, was weaker than ADNKA following natural infection, and was not boosted by the second dose. These insights have important implications for understanding disease progression, vaccine efficacy, and vaccine design.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Atanas Radkov et al.
    Research Article

    Members of the bacterial T6SS amidase effector (Tae) superfamily of toxins are delivered between competing bacteria to degrade cell wall peptidoglycan. Although Taes share a common substrate, they exhibit distinct antimicrobial potency across different competitor species. To investigate the molecular basis governing these differences, we quantitatively defined the functional determinants of Tae1 from Pseudomonas aeruginosa PAO1 using a combination of nuclear magnetic resonance (NMR) and a high-throughput in vivo genetic approach called deep mutational scanning (DMS). As expected, combined analyses confirmed the role of critical residues near the Tae1 catalytic center. Unexpectedly, DMS revealed substantial contributions to enzymatic activity from a much larger, ring-like functional hot spot extending around the entire circumference of the enzyme. Comparative DMS across distinct growth conditions highlighted how functional contribution of different surfaces is highly context-dependent, varying alongside composition of targeted cell walls. These observations suggest that Tae1 engages with the intact cell wall network through a more distributed three-dimensional interaction interface than previously appreciated, providing an explanation for observed differences in antimicrobial potency across divergent Gram-negative competitors. Further binding studies of several Tae1 variants with their cognate immunity protein demonstrate that requirements to maintain protection from Tae activity may be a significant constraint on the mutational landscape of tae1 toxicity in the wild. In total, our work reveals that Tae diversification has likely been shaped by multiple independent pressures to maintain interactions with binding partners that vary across bacterial species and conditions.